Dr Reddy's Laboratories Ltd
NSE:DRREDDY

Watchlist Manager
Dr Reddy's Laboratories Ltd Logo
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Watchlist
Price: 1 250.8 INR 0.37% Market Closed
Market Cap: 1T INR

During the last 3 months Dr Reddy's Laboratories Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 4% over this period (open performance analysis).

The last transaction was made on Jun 3, 2023 by C Swaminathan , who bought 1.8m INR worth of DRREDDY shares.

Last Transactions:
C Swaminathan
₹+8.9m
Manish Bajaj
₹+19.7m
Arun Gupta
₹+15m
View All Transactions

During the last 3 months Dr Reddy's Laboratories Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 4% over this period (open performance analysis).

The last transaction was made on Jun 3, 2023 by C Swaminathan , who bought 1.8m INR worth of DRREDDY shares.

Sold
0-3
months
0 INR
0
3-6
months
0 INR
0
6-9
months
0 INR
0
9-12
months
0 INR
0
Bought
0-3
months
No Insider Transactions
0
0 INR
3-6
months
No Insider Transactions
0
0 INR
6-9
months
No Insider Transactions
0
0 INR
9-12
months
No Insider Transactions
0
0 INR

Dr Reddy's Laboratories Ltd
Insider Trading Chart

Dr Reddy's Laboratories Ltd
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Dr Reddy's Laboratories Ltd
Last Insider Transactions

Global
Insiders Monitor

Dr Reddy's Laboratories Ltd
Glance View

In the bustling world of pharmaceuticals, Dr. Reddy's Laboratories Ltd. stands as a testament to innovation and resilience. Founded in 1984 by Dr. K. Anji Reddy, the company embarked on a journey to provide affordable and accessible medicine. Dr. Reddy's merged scientific rigor with a clear vision to eliminate health disparities worldwide. From creating complex generics and active pharmaceutical ingredients (APIs) to providing differentiated formulations, the company has built a strong foundation in both developed markets, like the United States and Europe, as well as in emerging markets such as India, Russia, and the CIS countries. This global footprint ensures that while many pharmaceutical companies are battling regulatory challenges and pricing pressures, Dr. Reddy's stays agile and competitive. The company's revenue streams primarily derive from its diverse portfolio of generic drugs, APIs, branded formulations, biologics, and proprietary products. Each sector is a strategic puzzle piece that enhances its market presence and ensures supply chain efficiency. Dr. Reddy's invests heavily in research and development to bolster its pipeline of future medications, aiming to address unmet medical needs and introduce value-added products. By leveraging strategic alliances and forging partnerships in development and distribution, the company adeptly navigates the complex landscape of the pharmaceutical industry, ensuring sustainable growth and reaffirming its commitment to affordable healthcare globally.

DRREDDY Intrinsic Value
HIDDEN
Show

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top